Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exiqon Appoints President and General Manager of new US Operations

Published: Friday, January 06, 2006
Last Updated: Friday, January 06, 2006
Bookmark and Share
Michael Kallelis will have the overall responsibility for launching and operating Exiqon’s US office to be located in the Boston area.

Exiqon A/S has announced the appointment of Michael Kallelis as President and General Manager of Exiqon’s new US operations.

Mr. Kallelis will have the overall responsibility for launching and operating Exiqon’s US office to be located in the Boston area.

A key focus of the new facility will be to expand the sales force to support Exiqon’s miRCURY™ microRNA detection products.

Before joining Exiqon, Mr. Kallelis served as a Vice President at Archemix Corp and prior to that as the Executive Vice President and General Manager of Avecia Biotechnology.

He also served as Chief Operating Officer and co-founder of Boston BioSystems, a leading GMP manufacturer of oligonucleotides, which was acquired by Avecia in 1999.

Over his career, Mr. Kallelis has acquired significant expertise in rapidly building up new businesses from start-up to commercially viable enterprises and has taken a lead management role in mergers and acquisitions.

"Mike possesses the commercial and operational leadership skills which will secure a strong launch of Exiqon’s US operations," said Lars Kongsbak, President and CEO of Exiqon.

"Mike also has extensive experience managing technical life science companies and brings the perfect blend of sales, marketing and operations roles that make him a good match for Exiqon’s growing business."

"During 2005, Exiqon has continued to grow its product sales, quarter to quarter, and a full presence in the US market is an obvious next step," said Jack Johansen, Chairman of the Board of Exiqon. "We are very pleased to have Mike lead this important operation."

Exiqon’s new offices will be located in the Boston area to take full advantage of the life science labor pool and large biotech presence.

The new US office plans to begin recruiting its sales staff and administrative support roles immediately. The site will be operational in the first quarter of this year.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exiqon Secures Funding to Accelerate Growth
Exiqon A/S has announced the issue of a senior secured note in the amount of DKK 40 million (‘Note’).
Thursday, November 12, 2015
Exiqon Licenses Biomarkers From Aarhus University Hospital
Exiqon A/S has exclusively licensed prostate cancer biomarkers discovered and validated by Aarhus University Hospital, Department of Molecular Medicine (MOMA).
Wednesday, December 03, 2014
Redefining High Risk Patients With Stage II Colon Cancer
microRNA-21 identified as an independent prognostic biomarker.
Friday, September 12, 2014
Exiqon Licenses Locked Nucleic Acids for Infectious Disease Diagnostics to BD
BD will use Exiqon's proprietary LNA™ technology in defined products for infectious disease diagnostics.
Wednesday, June 23, 2010
Exiqon and MultiD Sign Development and Distribution Agreement for microRNA qPCR Analysis Solution
Agreement incorporates a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform.
Wednesday, May 26, 2010
Exiqon Wins Ernst & Young Entrepeneur of the Year Award
Exiqon selected as winner in the BIOTECH 2005 category.
Tuesday, November 22, 2005
Exiqon A/S appoints permanent CEO

Monday, February 24, 2003
Scientific News
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
Genetic Mutation that Prevents Diabetes Complications
The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
Neanderthal DNA Influences Human Disease Risk
Large-scale, evolutionary analysis compares genetic data alongside electronic health records.
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH has announced that decipher the genome of the blacklegged tick which could lead to new tick control methods.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
New Source of Mutations in Cancer
Recently, a new mutation signature found in cancer cells was suspected to have been created by a family of enzymes found in human cells called the APOBEC3 family.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!